Valuation: Arvee Laboratories (India) Ltd.

Market Cap 147.51Cr 1.54Cr 1.33Cr 1.25Cr 1.14Cr 2.14Cr 2.17Cr 15Cr 5.74Cr 74Cr 5.79Cr 5.67Cr 245.84Cr P/E 2024
151x
P/E 2025 72.9x
Enterprise Value 143.64Cr 1.5Cr 1.3Cr 1.22Cr 1.11Cr 2.08Cr 2.11Cr 14Cr 5.59Cr 72Cr 5.64Cr 5.52Cr 239.38Cr EV / Sales 2024
5.18x
EV / Sales 2025 3.96x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day-0.28%
1 week+5.77%
Current month+5.63%
1 month+4.77%
3 months+1.25%
6 months+2.22%
Current year-22.40%
1 week 155.1
Extreme 155.1
189.39
1 month 147.15
Extreme 147.15
189.39
Current year 129.11
Extreme 129.11
208
1 year 129.11
Extreme 129.11
290.78
3 years 104
Extreme 104
315
5 years 62.9
Extreme 62.9
315
10 years 18.8
Extreme 18.8
315
Manager TitleAgeSince
Chief Executive Officer 52 01/04/2014
Director of Finance/CFO 43 10/05/2018
Compliance Officer 35 15/02/2019
Director TitleAgeSince
Chairman 52 01/04/2014
Director/Board Member 43 12/08/2025
Director/Board Member 43 12/02/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%+5.77%-2.27%+47.81% 1.91Cr
+0.20%+4.40%+37.96%+41.01% 7.45TCr
-1.25%-2.17%+8.98%+10.43% 5.1TCr
-1.42%+0.54%+8.19%+31.44% 1.8TCr
+0.29%+0.89%+50.26%+85.54% 1.44TCr
-1.20%-2.05%+50.49%+41.30% 1.03TCr
-1.21%-4.08%+12.88%-15.40% 1.03TCr
-0.79%+0.99%+5.03% - 973.39Cr
+0.05%-0.23%-8.17%+13.45% 808.81Cr
+2.34%+3.70%+87.31%-24.37% 729.12Cr
Average -0.33%+1.30%+25.07%+25.69% 2.04TCr
Weighted average by Cap. -0.43%+1.57%+26.66%+28.81%

Financials

2024 2025
Net sales 30Cr 31.74L 27.4L 25.7L 23.41L 44.02L 44.63L 3.01Cr 1.18Cr 15Cr 1.19Cr 1.17Cr 51Cr 38Cr 40.25L 34.75L 32.6L 29.69L 55.83L 56.61L 3.82Cr 1.5Cr 19Cr 1.51Cr 1.48Cr 64Cr
Net income 1.05Cr 1L 94.97T 89.1T 81.15T 2L 2L 10.44L 4L 52.7L 4L 4L 1.75Cr 2.15Cr 2L 2L 2L 2L 3L 3L 21.32L 8L 1.08Cr 8L 8L 3.58Cr
Net Debt -86.55L -90.52T -78.15T -73.31T -66.77T -1L -1L -9L -3L -43.36L -3L -3L -1.44Cr -3.87Cr -4L -3L -3L -3L -6L -6L -38.46L -15.07L -1.94Cr -15.21L -14.88L -6.45Cr
Logo Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Limited is an India-based company. The Company is engaged in manufacturing of specialized chemicals. It operates through Textile and Non-Textile segments. It offers polymer modifiers, contrast media intermediates, and drug intermediates. Its polumer modifier products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt, and 5-Sodiosulfo-Bis-Isophthalate. Its contrast media intermediate products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, 3,5-Dinitrobenzoic Acid, and 3,5-Diamino Benzoic Acid. Its drug intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine, and 2-Chloro-5-Nitrobenzoic Acid.
Employees
-
Date Price Change Volume
17/26/17 165.55 -0.28% 616
14/26/14 ₹166.01 -1.61% 1,929
13/26/13 ₹168.72 -4.81% 5,224
12/26/12 ₹177.24 +0.27% 17,422
11/26/11 ₹176.76 +13.97% 77,723
  1. Stock Market
  2. Stocks
  3. ARVEE Stock